Fighting Childhood Leukemia

The Fighting Childhood Leukemia program of the National Cancer Center provides research funding for the most common form of cancer in children: leukemia. Childhood leukemia accounts for more than one-third of all new cases of childhood cancers.

Research funded at Harvard’s Dana-Farber Cancer Institute seeks to discover novel molecular markers and potential therapeutic targets that, in time, can lead to improved diagnosis and prognosis of acute myeloid leukemia patients.

DONATE NOW

Fighting Childhood Leukemia

Current Grants and Renewals

National Cancer Center has been proud to award grants to many fine research organizations. We know that a cure lies in research and we are committed to supporting as many research projects as we can.

Jungmin Lee, Ph.D.

The University of California, San Francisco

PROJECT: Synthetic control of effector T cell infiltration into immune-excluded tumors

NEW GRANT

Narek Darabedian, Ph.D.

Dana-Farber Cancer Inst, Boston, MA

PROJECT: Covalent manipulation of undrugged metabolic proteins to treat cancer

RENEWAL

Past Beneficiaries

Robin Armstrong, Ph.D.

Memorial Sloan Kettering, New York, NY

PROJECT: Determining differential roles for p53 loss-of-function and R270H mutants during leukemia development

2021-2022

Sohini Chakraborty, Ph.D.

New York Univ School of Medicine, New York, NY

PROJECT: Therapeutic targeting of stem cells in pediatric acute myeloid leukemia

2020-2022

Shixin Ma, Ph.D.

The Salk Inst for Biological Studies

PROJECT: Metabolically harnessing anti-tumor CD8 T cells at epigenetic level

2019-2021

Darko Barisic, Ph.D.

Weill Medical College of Cornell Univ

PROJECT: Role of chromatin remodeling complex BAF in lymphomagenesis
2019-2020

Johannes Christian Hellmuth, Ph.D.

Weill Cornell College of Cornell Univ

PROJECT:eRNA Processing by Integrator in Lymphoma Pathogenesis
2018-2019

Johannes Christian Hellmuth, Ph.D.

Weill Cornell College of Cornell Univ

PROJECT:eRNA Processing by Integrator in Lymphoma Pathogenesis
2016

Shelly L. Rozen, Ph.D.

Dana-Farber Cancer Institute

PROJECT: The Oncogene SET intersects the FLT3-C/EBPalpha Axis in Granulopoiesis and Leukemia
2016-2015